| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely enfuvirtide 90 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cefotaximnatrium 2 gram/injektionsflaska, pulver till injektionsvätska |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| cefotaximnatrium 2 gram/injektionsflaska, pulver till injektionsvätska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Ertapenem (as ertapenem sodium) 1 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Ertapenem (as ertapenem sodium) 1 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely streptokinase 750000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely streptokinase 750000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Botulism immunoglobulin 100 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Botulism immunoglobulin 100 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefoperazone (as cefoperazone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefoperazone (as cefoperazone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Trastuzumab 440 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Trastuzumab 440 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Drotrecogin alfa 5 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Drotrecogin alfa 5 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Warfarin sodium 5 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Warfarin sodium 5 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Somatrem 10 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Somatrem 10 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| humant immunglobulin G 6 gram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| humant immunglobulin G 6 gram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
2 |
| Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
2 |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
2 |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
FHIR